ISU Abxis Co., Ltd. (KOSDAQ:086890)
South Korea · Delayed Price · Currency is KRW 3,850.00
+170.00 (4.62%)
At close: Oct 16, 2026
ISU Abxis Market Cap
ISU Abxis has a market cap or net worth of 156.98 billion as of October 16, 2026. It is the 24,508th most valuable company in the world and the 1,005th biggest in South Korea. Its market cap has decreased by 23.27% in one year.
Market Cap
156.98B
Enterprise Value
155.65B
Revenue
51.04B
Global Rank
Country Rank
#1,005 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since February 3, 2009, ISU Abxis's market cap has increased from 55.97B to 156.98B, an increase of 180.49%. That is a compound annual growth rate of 6.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 156.98B | -23.69% |
| Dec 30, 2025 | 205.73B | 28.77% |
| Dec 30, 2024 | 159.77B | -23.70% |
| Dec 28, 2023 | 209.40B | 9.75% |
| Dec 29, 2022 | 190.80B | -34.58% |
| Dec 30, 2021 | 291.68B | 43.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IMBiologics | 225.66B |
| IntoCell | 216.02B |
| curacle co.,ltd. | 197.86B |
| Kangstem Biotech | 180.30B |
| NIBEC | 164.26B |
| Bio Solution | 157.92B |
| Ensol Biosciences | 140.17B |
| Kanaph Therapeutics | 133.27B |